Can hysterectomy be considered a risk factor for cardiovascular disease?

Circulation

Volumn 111, Issue 12, 2005, Pages 1456-1458

  Brett, Kate M ^a,b  

^a NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

^b U S PUBLIC HEALTH SERVICE   (United States)

Author keywords

Cardiovascular diseases; Editorials; Menopause; Risk factors; Women

Indexed keywords

IRON; SEX HORMONE;

CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; EDITORIAL; FEMALE; HORMONE ACTION; HUMAN; HYSTERECTOMY; IRON STORAGE; MENOPAUSE; OSTEOPOROSIS; OVARIECTOMY; PRIORITY JOURNAL; RISK FACTOR;

CARDIOVASCULAR DISEASES; FEMALE; HORMONES; HUMANS; HYSTERECTOMY; IRON; RISK FACTORS;

EID: 16344393584     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000161141.92300.F3     Document Type: Editorial

References (20)

1. Howard BV, Kuller L, Langer R, Manson JE, Allen C, Assaf A, Cochrane BB, Larson JC, Lasser N, Rainford M, Van Horn L, Stefanick ML, Trevisan M. Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy: the Women's Health Initiative observational study. Circulation. 2005;111:1462-1470.
2. Kozak LJ, Owings MF, Hall MJ. National Hospital Discharge Survey: 2001 annual summary with detailed diagnosis and procedure data. Vital Health Stat 13, 2004; Jun: 1-198.
3. Lepine LA, Hillis SD, Marchbanks PA, Koonin LM, Morrow B, Kieke BA, Wilcox LS. Hysterectomy surveillance-United States, 1980-1993. MMWR CDC Surveill Summ. 1997;46:1-15.
4. Brett KM, Marsh JV, Madans JH. Epidemiology of hysterectomy in the United States: demographic and reproductive factors in a nationally representative sample. J Womens Health. 1997;6:309-316.
5. Kjerulff K, Langenberg P, Guzinski G. The socioeconomic correlates of hysterectomies in the United States. Am J Public Health. 1993;83:106-108.
6. Bachmann GA. Hysterectomy. A critical review. J Reprod Med. 1990;35:839-862.
7. McKinlay SM. The normal menopause transition: an overview. Maturitas. 1996;23:137-145.
8. Crawford SL. Epidemiology: methodologic challenges in the study of menopause. In: Lobo RA, Kelsey J, Marcus R, eds. Menopause: Biology and Pathobiology. San Diego, Calif: Academic Press; 2000: 159-174.
9. Derby CA. Cardiovascular pathophysiology. In: Lobo RA. Kelsey J. Marcus R, eds. Menopause: Biology and Pathobiology. San Diego. Calif: Academic Press; 2000: 229-243.
10. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med. 1987;316:1105-1110.
11. Stone SC, Dickey RP, Mickal A. The acute effect of hysterectomy on ovarian function. Am J Obstet Gynecol. 1975;121:193-197.
12. Cooper GS, Thorp JM Jr. FSH levels in relation to hysterectomy and to unilateral oophorectomy. Obstet Gynecol. 1999;94:969-972.
13. Nahas E, Pontes A, Traiman P, NahasNeto J, Dalben I, De Luca L. Inhibin B and ovarian function after total abdominal hysterectomy in women of reproductive age. Gynecol Endocrinol. 2003;17:125-131.
14. Massart F, Reginster JY, Brandi ML. Genetics of menopause-associated diseases. Maturitas. 2001;40:103-116.
15. Mercuro G, Zoncu S, Cherchi A, Rosano GM. Can menopause be considered an independent risk factor for cardiovascular disease? Ital Heart J. 2001;2:719-727.
16. Sowers MR, La Pietra MT. Menopause: its epidemiology and potential association with chronic diseases. Epidemiol Rev. 1995;17:287-302.
17. Snowdon DA, Kane RL, Beeson WL, Burke GL, Sprafka JM, Potter J, Iso H, Jacobs DR Jr, Phillips RL. Is early natural menopause a biologic marker of health and aging? Am J Public Health. 1989;79:709-714.
18. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML. Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333.
19. Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby LK, Waters D, Vittinghoff E, Wenger N; HERS Research Group. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA. 2002;288:49-57.
20. Sempos CT, Gillum RF, Looker AC. Iron and heart disease: a review of the epidemiologic data. In: Bendich A, Deckelbaum RJ, eds. Preventive Nutrition: The Comprehensive Guide for Health Professionals. Totowa, NJ: Humana Press; 2001: 175-189.